Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).

S. A. Eccles, G. Box, William Court, +3

PubMed

Breast OncologyPathologyCancer BiologyTumor BiologyOncology +15

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

Pornchai O‐charoenrat, Helmout Modjtahedi, P. Rhys‐Evans, +3

PubMed

PathologyDermatologyCancer BiologyTumor BiologyCancer Cell Biology +15

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction

Helmout Modjtahedi, S. A. Eccles, G. Box, +2

British Journal of Cancer

Tumor BiologyHuman Tumour XenograftsMedicineImmunologyRat Antibodies +6

Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.

Helmout Modjtahedi, S. A. Eccles, J Sandle, +3

PubMed

Terminal DifferentiationRat Monoclonal AntibodiesMedicineImmunologyTumor Immunity +13

Treatment of implanted liver tumors with focused ultrasound

L Chen, Gail ter Haar, Christopher Hill, +1

Ultrasound in Medicine & Biology

Immunotherapy with antibodies to the EGF receptor

Christopher Dean, Helmout Modjtahedi, S. A. Eccles, +2

International Journal of Cancer

Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor

Helmout Modjtahedi, S. A. Eccles, G. Box, +2

Cell Biophysics

Cancer ImmunosurveillanceAntitumor ActivityImmunologyAntibody EngineeringHuman Egf Receptor +7

In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance

Prakash Mistry, Jane A. Plumb, Sue Eccles, +7

British Journal of Cancer

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour

CL Flemming, SJ Russell, I. McKay, +4

British Journal of Cancer

InflammationCytokineSingle TumourInterleukin 2Immunology +8

Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer

Christopher Dean, S. A. Eccles, M Valeri, +5

Cell Biophysics

Breast OncologyRat MabsOncogenic AgentMalignant DiseaseImmunology +6